Evidence map›Paper›PMID 33718582›Full record

ReviewAlzheimer's & dementia (Amsterdam, Netherlands)2021

The application of optical coherence tomography angiography in Alzheimer's disease: A systematic review.

Olivia M Rifai, Sarah McGrory, Cason B Robbins, Dilraj S Grewal, Andy Liu, Sharon Fekrat, Thomas J MacGillivray

Open access · goldAbstract readReview
In one paragraph

Review in Alzheimer's & dementia (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 5 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 5 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Multimodal imaging in neuro-ophthalmology.Indian journal of ophthalmology · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. A deep-learning retinal aging biomarker for cognitive decline and incident dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Alzheimer's disease pathophysiology in the Retina.Progress in retinal and eye research · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Olivia M RifaiTranslational Neuroscience PhD Programme University of Edinburgh Edinburgh UK.
Sarah McGroryCentre for Clinical Brain Sciences College of Medicine and Veterinary Medicine University of Edinburgh Edinburgh UK.
Cason B RobbinsDepartment of Ophthalmology Duke University School of Medicine Durham North Carolina USA.
Dilraj S GrewalDepartment of Ophthalmology Duke University School of Medicine Durham North Carolina USA.
Andy LiuDepartment of Neurology Duke University School of Medicine Durham North Carolina USA.
Sharon FekratDepartment of Ophthalmology Duke University School of Medicine Durham North Carolina USA.
Thomas J MacGillivrayCentre for Clinical Brain Sciences College of Medicine and Veterinary Medicine University of Edinburgh Edinburgh UK.
Duke University · USUniversity of Edinburgh · GBMRC Centre for Regenerative Medicine · GB

Funding

Medical Research Council MC_PC_15027Wellcome Trust
6 · The paper itself

Abstract

introductionDiscovering non-invasive and easily acquired biomarkers that are conducive to the accurate diagnosis of dementia is an urgent area of ongoing clinical research. One promising approach is retinal imaging, as there is homology between retinal and cerebral vasculature. Recently, optical coherence tomography angiography (OCT-A) has emerged as a promising new technology for imaging the microvasculature of the retina.

methodsA systematic review and meta-analysis was conducted to examine the application of OCT-A in dementia.

resultsFourteen studies assessing OCT-A in preclinical Alzheimer's disease (AD), mild cognitive impairment, or AD were included. Exploratory meta-analyses revealed a significant increase in the foveal avascular zone area and a significant decrease in superficial parafoveal and whole vessel density in AD, although there was significant heterogeneity between studies. DISCUSSION: Although certain OCT-A metrics may have the potential to serve as biomarkers for AD, the field requires further standardization to allow conclusions to be reached regarding their clinical utility.

Indexed as

Alzheimer's diseasedementiadiagnostic toolfoveal avascular zonemild cognitive impairmentoptical coherence tomography angiographyperfusion densitypreclinicalretinal imagingretinal vasculaturevessel density

Identifiers

PMID33718582
PMCPMC7927164
OpenAlexW3134678575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.